Results 1 to 10 of about 149,498 (247)

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease [PDF]

Frontiers in Pharmacology, 2023
Objective: To summarize the situation of antineoplastic agents-induced interstitial lung diseases (ILD), provide reference for strengthening clinical management of druginduced interstitial lung diseases (DILD).Methods: We retrospectively investigated the
Xiao Li, Yong-Li Gu, Xu-Chao Liu, Zeng-Xian Sun, Ying Sun   +4 more
doaj   +4 more sources

Adaptation of Bacteria to Antineoplastic Agents Involves Persister Cells and Increases Resistance to Antibiotics [PDF]

Bioengineering, 2022
The increasing number of life-threatening infections observed in cancer patients has been ascribed to chemotherapy-induced neutropenia and to invasive medical procedures such as surgery and the application of catheters.
Carla C. C. R. de Carvalho
doaj   +2 more sources

Extravasation of antineoplastic agents: prevention and treatments

Pediatric Reports, 2012
The extravasation of antineoplastic agents is an unwanted and distressing situation that can easily occur. It may cause severe and irreversible local injuries.
Rita Boschi, Elena Rostagno
doaj   +3 more sources

Public procurement of antineoplastic agents used for treating breast cancer in Brazil between 2013 and 2019 [PDF]

BMC Cancer, 2022
Background Breast cancer is the most common cancer among women in Brazil and the country’s public health care system is the main care provider. Timely treatment can increase the chance of cure, prevent metastasis and improve quality of life.
Ranailla Lima Bandeira dos Santos, Vera Lúcia Edais Pepe, Claudia Garcia Serpa Osorio-de-Castro   +2 more
doaj   +2 more sources

Antineoplastic Agents Targeting Sphingolipid Pathways [PDF]

Frontiers in Oncology, 2020
Emerging studies in the enigmatic area of bioactive lipids have made many exciting new discoveries in recent years. Once thought to play a strictly structural role in cellular function, it has since been determined that sphingolipids and their ...
Alexander Kroll, Hwang Eui Cho, Hwang Eui Cho, Min H. Kang, Min H. Kang   +4 more
doaj   +2 more sources

Drug–Drug Interactions of 257 Antineoplastic and Supportive Care Agents With 7 Anticoagulants: A Comprehensive Review of Interactions and Mechanisms

Clinical and Applied Thrombosis/Hemostasis, 2020
Data on drug–drug interactions (DDI) of antineoplastic drugs with anticoagulants is scarce. We aim to evaluate factors associated with DDI of antineoplastic and supportive care drugs with anticoagulants resulting in modification of pharmacokinetics of ...
Érique José F. Peixoto de Miranda MD, PhD, Thamy Takahashi Pharm B., Felipe Iwamoto Pharm B., Suzete Yamashiro DDS, Eliana Samano MD, MBA, Ariane Vieira Scarlatelli Macedo MD, MSc, Eduardo Ramacciotti MD, PhD   +6 more
doaj   +2 more sources

Metformin Adjunct With Antineoplastic Agents for the Treatment of Lung Cancer: A Meta-Analysis of Randomized Controlled Trials and Observational Cohort Studies

Frontiers in Pharmacology, 2021
Objective: Resistance to anticancer agents ensures a poor prognosis in patients with lung cancer. Metformin could enhance the anticancer effects of standard antineoplastic agents [traditional chemotherapy drugs, epidermal growth factor receptor tyrosine ...
Xiaofeng Luo, Xiaofeng Luo, Xi Chen, Xi Chen, Lin Wang, Lin Wang, Bowen Yang, Shuang Cai, Shuang Cai   +8 more
doaj   +1 more source

Prediction of the permeability of antineoplastic agents through nitrile medical gloves by zone classification based on their physicochemical properties

Journal of Pharmaceutical Health Care and Sciences, 2020
Background Permeability of antineoplastic agents through medical gloves is an important factor that must be considered for the appropriate selection of gloves.
Toyohito Oriyama, Takehito Yamamoto, Katsuhiko Nara, Yohei Kawano, Katsuyoshi Nakajima, Hiroshi Suzuki, Takao Aoyama   +6 more
doaj   +1 more source

Overall Survival Prediction of Docetaxel-based Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis

Oman Medical Journal, 2022
Objectives: Non-small cell lung cancer (NSCLC) accounts for 75–85% of all lung cancer diagnoses. This meta-analysis sought to estimate the overall survival (OS) of NSCLC based on randomized control trials which had compared docetaxel with kinase ...
Chaitra Nagaraju, Gayatri Vaidya, Anisha S. Jain, Amrutha Puthiyidath Nair, Sahana Chandrappa, Chandrashekar Srinivasa, Kuralayanapalya Puttahonnappa Suresh, Sharanagouda S. Patil, Bindya Shivananda, Shiva Prasad Kollur, Chandan Shivamallu   +10 more
doaj   +1 more source

Evaluating New Antineoplastic Agents [PDF]

Ca-A Cancer Journal for Clinicians, 1972
exaly   +3 more sources